BSE - Delayed Quote INR
Gennex Laboratories Limited (GENNEX.BO)
13.24
-0.58
(-4.20%)
At close: April 25 at 3:45:43 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,234,668.25
791,006.25
649,620.44
611,791.38
596,261.52
Cost of Revenue
906,488.70
500,531.70
408,596.56
386,743.20
366,950.91
Gross Profit
328,179.56
290,474.56
241,023.88
225,048.19
229,310.61
Operating Expense
118,356.85
143,855.85
203,290.79
174,247.69
172,297.27
Operating Income
209,822.71
146,618.71
37,733.10
50,800.50
57,013.34
Net Non Operating Interest Income Expense
6,533.54
7,187.54
13,076.11
227.89
-6,896.93
Pretax Income
227,470.81
164,917.81
63,729.96
50,935.11
50,621.78
Tax Provision
31,567.55
33,167.55
14,522.19
11,702.78
10,240.27
Net Income Common Stockholders
188,455.26
131,750.26
49,207.77
39,232.32
40,381.51
Diluted NI Available to Com Stockholders
188,455.26
131,750.26
49,207.77
39,232.32
40,381.51
Basic EPS
0.84
0.67
0.32
0.31
0.30
Diluted EPS
0.78
0.61
0.32
0.31
0.30
Basic Average Shares
218,788.33
186,817.06
146,070.21
126,503
132,599.53
Diluted Average Shares
248,665.76
216,694.50
146,070.21
126,503
132,599.53
Rent Expense Supplemental
--
965.53
1,907.68
3,796.31
2,282.48
Total Expenses
1,024,845.54
644,387.54
611,887.34
560,990.89
539,248.19
Net Income from Continuing & Discontinued Operation
188,455.26
131,750.26
49,207.77
39,232.32
40,381.51
Normalized Income
183,465.35
127,121.54
46,988.99
42,983.70
43,343.04
Interest Income
--
37,947.73
26,614.09
9,002.28
538.16
Interest Expense
31,414.19
30,760.19
13,537.98
8,774.39
7,435.09
Net Interest Income
6,533.54
7,187.54
13,076.11
227.89
-6,896.93
EBIT
258,885
195,678
77,267.95
59,709.50
58,056.87
EBITDA
275,671.74
219,357
86,462.09
67,594.12
66,864.25
Reconciled Cost of Revenue
906,488.70
500,531.70
408,596.56
386,743.20
366,950.91
Reconciled Depreciation
16,786.74
23,679
9,194
7,884.62
8,807.38
Net Income from Continuing Operation Net Minority Interest
188,455.26
131,750.26
49,207.77
39,232.32
40,381.51
Total Unusual Items Excluding Goodwill
5,793.97
5,793.97
2,873.59
-4,870.39
-3,712.54
Total Unusual Items
5,793.97
5,793.97
2,873.59
-4,870.39
-3,712.54
Normalized EBITDA
269,877.77
213,563.03
83,588.51
72,464.50
70,576.78
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
804.07
1,165.26
654.81
-1,119.01
-751.01
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade